Dorzolamide/timolol
| Combination of | |
|---|---|
| Dorzolamide | Carboanhydrase inhibitor |
| Timolol | Beta blocker |
| Clinical data | |
| Trade names | Cosopt |
| Pregnancy category |
|
| Routes of administration | eye drops |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| (verify) | |
Dorzolamide/timolol eye drops (trade name Cosopt) are used for lowering pressure in the eye to normal levels, and as a treatment for glaucoma. The drug is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. Both chemicals work by decreasing the production of aqueous humor. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.